Open Search
Close Search

Health Care

Showing press and news related to: Health Care

Lawmakers Reintroduce Bipartisan, Bicameral Legislation to Increase Access to Medicare Home Infusion Benefit

WASHINGTON – U.S. Sens. Mark R. Warner (D-VA) and Tim Scott (R-SC) joined by U.S. Reps. Vern Buchanan (R-FL-16), Chairman of the House Ways & Means Health Subcommittee, Debbie Dingell…

Warner & Scott Reintroduce Bipartisan Legislation to Improve Hiring of Caregivers for Seniors

WASHINGTON – Today, U.S. Sens. Mark R. Warner (D-VA) and Tim Scott (R-SC) reintroduced bipartisan legislation to protect seniors by empowering nursing homes to better screen and vet potential employees.…

Warner, Kaine, Moran Introduce Bipartisan Legislation to Strengthen Childhood Cancer Research

WASHINGTON – Today, during Brain Cancer Awareness Month, U.S. Sens. Mark Warner, Tim Kaine (both D-VA), and Jerry Moran (R-KS) introduced the Gabriella Miller Kids First Research Act 2.0. This…

Statement of U.S. Sen. Mark R. Warner on the End of the COVID-19 Public Health Emergency

WASHINGTON – U.S. Sen. Mark R. Warner (D-VA) released the statement below on the official end of the nation’s Public Health Emergency (PHE) for COVID-19: “When COVID-19 hit, Congress acted with…

Statement of U.S. Sen. Mark R. Warner on DEA Extension of Current Flexibilities Around Telehealth Prescriptions of Certain Medications

WASHINGTON – U.S. Sen. Mark R. Warner (D-VA) released the statement below after the Drug Enforcement Agency (DEA) announced that it would extend current flexibilities around telehealth prescriptions of controlled substances,…

Warner, Kaine & Colleagues Urge Appeals Court to Prevent Dangerous Ruling Threatening Access to Mifepristone from Taking Effect

WASHINGTON – Today, following a federal district court judge’s ruling suspending the Food and Drug Administration (FDA)’s 2000 approval of mifepristone, U.S. Sens. Mark R. Warner and Tim Kaine, along…

Statement of U.S. Sen. Mark R. Warner on the Approval of Narcan sales without a Prescription

WASHINGTON – U.S. Sen. Mark R. Warner (D-VA), released the statement below after Federal Drug Administration (FDA) today authorized the over-the-counter sale of Narcan, a nasal spray drug that rapidly reverses…

Warner, Blackburn Lead Bipartisan Effort to Preserve Access to Rural Health Care

WASHINGTON – Today, U.S. Sens. Mark R. Warner (D-VA) and Marsha Blackburn (R-TN), joined by Sens. Tim Kaine (D-VA), John Cornyn (R-TX), Rev. Raphael Warnock (D-GA), John Boozman (R-AR), Cindy…

Statement of Senate Intel Chairman Mark R. Warner on New Voluntary Cybersecurity Guidance from HHS for Health Care Organizations

WASHINGTON – U.S. Sen. Mark R. Warner (D-VA), Chairman of the Senate Intelligence Committee, released the following statement today after the Department of Health and Human Services (HHS) issued new voluntary cybersecurity guidance for…

Warner, Kaine, Colleagues Reintroduce Women’s Health Protection Act to Ensure Equal Access to Reproductive Health Care

WASHINGTON – Today, U.S. Sens. Mark R. Warner and Tim Kaine (both D-VA) joined Sens. Tammy Baldwin (D-WI), Richard Blumenthal (D-CT) and 45 Senate colleagues in introducing the Women’s Health Protection…